Intellia Therapeutics advances in vivo and ex vivo CRISPR/Cas9 genome editing therapies for genetic diseases. Tailored for modern biology and life science teams.

Synthego provides CRISPR genome engineering tools, kits, and engineered cells to accelerate gene editing research. Tailored for modern biology and life science teams.

Mammoth Biosciences builds CRISPR-based diagnostics and genome-editing tools leveraging novel Cas proteins. Tailored for modern biology and life science teams.

Precision NanoSystems builds microfluidic manufacturing technologies for lipid nanoparticles, mRNA, and gene therapy delivery. Tailored for modern biology and life science teams.

Lonza is a CDMO providing development and manufacturing across biologics, cell therapy, and drug delivery. Tailored for modern biology and life science teams.

WuXi AppTec offers integrated R&D and manufacturing services covering discovery, chemistry, biologics, and cell & gene therapies. Tailored for modern biology and life science teams.

CRISPR Therapeutics is a clinical-stage gene editing company developing transformative therapies for serious diseases. Trusted by global research and diagnostic programs.

Editas Medicine is developing CRISPR genome editing medicines for ocular, hematologic, and oncologic diseases. Tailored for modern biology and life science teams.

bluebird bio develops gene therapies using lentiviral vectors to treat severe genetic diseases like thalassemia and sickle cell. Tailored for modern biology and life science teams.

Moderna develops mRNA medicines spanning infectious disease, oncology, rare disease, and autoimmune applications. Tailored for modern biology and life science teams.